🔗 Share this article

Given that America continues making unprecedented changes to its immunization schedules, an unexpected name has emerged in a surprising turn: Dr. Tracy Beth Høeg, a US-based physician and epidemiologist who initially gained attention by expressing skepticism about COVID-19 vaccines in the pandemic and has zeroed in on potential deaths following COVID-19 immunization in her short time at the FDA.

Proposed Changes to Pediatric Vaccine Schedule

Agency leaders planned to unveil major changes to the pediatric immunization program recently, bringing the US with Denmark’s national calendar, it is understood – a substantial departure that would put the US at odds with much of the global community with no evidence for benefit. The planned update has been delayed until the new year.

Instead of the top vaccines chief, Tracy Beth Høeg is scheduled to present at the gathering. She was recently named interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to lead the office this year.

A Shift at the Agency

Høeg's temporary position could signify a tighter collaboration between the pharmaceutical and biologics branches as Høeg and Prasad consolidate power at the agency – and it points to a greater focus upon dismantling already-approved vaccines at the FDA.

Høeg has repeatedly called for discontinuing certain pediatric shot schedules in the US so as to align more similar to the Danish model, a country with nationalized medicine and a population roughly the size of Wisconsin’s.

To date statements, she has kept her attention on vaccines – typically the domain of Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of medication approval.

Doubts Over Background

The appointee has little discernible experience in drug development, approval processes or management, which has been typical for past leaders of the Center for Biologics Evaluation and Research. She has served at the FDA as a top consultant to the agency head and CBER since March.

“It seems she lacks to have the requisite experience” for leading the CDER, said Jonathan Howard. “She has not conducted a clinical trial. She is not versed in managing a sizeable institution. She lacks background in drug approvals.”

Past directors of the center would “be deeply familiar with laws and regulations and the underlying principles of drug development”, commented Dr. Janet Woodcock. “Clearly, she lacks the type of experience that previous people who ran the center have had.”

This division has an enormous range of responsibilities at the FDA, she pointed out.

“Everybody just zeroes in on the innovative therapies, but the generic program authorizes numerous generic drugs. There’s a biologic copycat branch, OTC medication office and other areas, and all of those need to be managed,” she noted. “The thing you neglect, that’s the thing that I always told people is going to bite you.”

Additionally, a major administrative element to the position, which manages over 5,000 staff members. “It’s a massive management job, if you execute it properly,” the former official added.

Official Statement and Disputed Programs

In response to concerns about Høeg’s qualifications and whether this assignment indicates more teamwork among FDA leaders on immunizations, a representative responded that the “concerns are based on flawed premises”.

“Her resume aligns with the functions of her role,” the spokesperson stated, pointing to the time Dr. Høeg spent guiding the FDA commissioner on “drug safety and approval science, including computational safety modeling and shot safety tracking”.

As the temporary head, Høeg takes over the agency head's recently launched expedited review system, a contentious one-day drug-approval program that apparently worried her former heads. “How are these drugs being selected for this fast-track system? Who makes the calls?” Howard asked. “There’s a lot of confidentiality happening at the FDA right now.”

In general, he stated, “the Food and Drug Administration appears to be shifting towards laxer oversight of all drugs, except for immunizations.”

Documented Past Work on Immunizations

Concerning vaccines, Høeg has a more documented, if concerning, past, Howard observe. She authored a study using unverified volunteer-provided data to determine the incidence of myocarditis following Covid immunization. She consulted for the state of Florida surgeon general Joseph Ladapo, who allegedly have modified findings to indicate COVID-19 vaccinations are riskier than they are.

Among her “desired changes” for the new federal leadership included altering rules for new vaccines and halting “non-essential” vaccines, she said post-election on a online show. At the agency, Høeg has allegedly proposed barring young men from receiving Covid vaccines.

“She’s an all-around dogmatist who starts off with her beliefs and tailors the evidence to fit the evidence in a extremely disingenuous, untruthful manner,” Howard stated.

Taking Control and a “Push for Payback”

Dr. Høeg joined fellow skeptics, {like|